From GlobeNewswire: 2025-06-06 09:15:00

The global Ventricular Assist Device Market was valued at USD 1.6 billion in 2023 and is projected to reach USD 3.3 billion by 2032, growing at a CAGR of 8.8% during 2024–2032. The market is driven by the rising incidence of heart failure and advancements in medical devices for treating cardiovascular diseases.

In the U.S., the ventricular assist device market was estimated at USD 0.73 billion in 2023 and is expected to reach USD 1.48 billion by 2032, with a CAGR of 7.74% during 2024-2032. The U.S. holds a significant share in the market due to better healthcare facilities, R&D investments, and high heart failure incidences.

The Left Ventricular Assist Devices segment dominated the market in 2024 with an 83.5% market share, offering improved life quality for patients with end-stage heart failure. Continuous flow devices accounted for 89.9% market share in 2024 due to their superior durability and clinical outcomes over pulsatile flow devices.

Implantable devices held a 75.8% market share in 2024, providing better mobility and quality of life for patients with advanced heart failure. Destination therapy segment led the market with a 43.1% share in 2024, offering long-term cardiac support for patients ineligible for heart transplant, improving survival and quality of life.

North America dominated the ventricular assist device market in 2024, with 58.1% market share, driven by advanced healthcare infrastructure and high heart failure prevalence. Asia-Pacific is expected to show the fastest growth, fueled by healthcare investments, aging population, and rising cardiovascular diseases.

The Ventricular Assist Device Market offers segmentation by application, product, flow type, and design. SNS Insider provides comprehensive market research and consulting services to help clients navigate changing market conditions with confidence and make informed decisions.



Read more at GlobeNewswire: Ventricular Assist Device Market Size to Hit USD 3.3